Akebia Therapeutics, Inc.
|
-0.28 USD
|
-4421.429%
|
Jaguar Health, Inc.
|
-107.42 USD
|
88.214%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
-143.462%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
-429.707%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
-259.659%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
519.205%
|
ContextLogic Inc.
|
-13.36 USD
|
5.24%
|
MiMedx Group, Inc.
|
0.48 USD
|
2737.5%
|
MEI Pharma, Inc.
|
2.67 USD
|
574.157%
|
AlloVir, Inc.
|
-1.83 USD
|
-591.803%
|
Novavax, Inc.
|
-5.41 USD
|
-134.011%
|
Aptorum Group Limited
|
-0.62 USD
|
-1941.935%
|
Ardelyx, Inc.
|
-0.30 USD
|
-4120.0%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
-562.827%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
-61.274%
|
Vaxcyte, Inc.
|
-4.14 USD
|
-205.797%
|
Precigen, Inc.
|
-0.39 USD
|
-3146.154%
|
Pharming Group N.V.
|
-0.16 USD
|
-7812.5%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
-222.137%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
41.927%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
-779.167%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
-335.052%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
87.781%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-912.8%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-912.8%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
-149.213%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
-755.405%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
-1153.465%
|
Acelyrin, Inc.
|
-5.43 USD
|
-133.149%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
-844.776%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
-937.705%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
20.924%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
-431.933%
|
AbCellera Biologics Inc.
|
-0.51 USD
|
-2382.353%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
42.376%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
-105.854%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-6230.0%
|
Chimerix, Inc.
|
-0.93 USD
|
-1261.29%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
-732.895%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
86.273%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
-22.793%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
-859.091%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
-844.776%
|
Alkermes plc
|
2.14 USD
|
691.589%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-49.469%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-49.469%
|
Agenus Inc.
|
-13.75 USD
|
7.927%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
-46.698%
|
Dyadic International, Inc.
|
-0.24 USD
|
-5175.0%
|
ImmuCell Corporation
|
-0.75 USD
|
-1588.0%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-34584.932%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
-545.918%
|
Lantern Pharma Inc.
|
-1.47 USD
|
-761.224%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
-1322.472%
|
Incyte Corporation
|
2.67 USD
|
574.157%
|
IO Biotech, Inc.
|
-1.98 USD
|
-539.394%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
-859.091%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
-254.622%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
-168.22%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
-117.9%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
-291.95%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
-562.827%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
36.668%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
-824.088%
|
NextCure, Inc.
|
-2.25 USD
|
-462.667%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-2652.174%
|
Onconetix, Inc.
|
-2.19 USD
|
-478.082%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
5.733%
|
Opthea Limited
|
-0.35 USD
|
-3517.143%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
-810.791%
|
PureTech Health plc
|
-2.38 USD
|
-431.933%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
-584.324%
|
Seer, Inc.
|
-1.35 USD
|
-837.778%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-333057.895%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-2288.679%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-2777.273%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
-357.04%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-2244.444%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-2713.333%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
-374.157%
|
ChromaDex Corporation
|
-0.07 USD
|
-19110.926%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
-475.455%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
-817.391%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
-552.577%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
20.677%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
-671.951%
|
Innoviva, Inc.
|
2.92 USD
|
533.562%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
-1178.788%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
-755.405%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
-418.852%
|
ESSA Pharma Inc.
|
-0.60 USD
|
-2010.0%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-2082.759%
|
GT Biopharma, Inc.
|
-5.64 USD
|
-124.468%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
-147.266%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
1989.552%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
-755.405%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
13.995%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
-333.562%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
-67.018%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
98.838%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
-450.435%
|
Kura Oncology, Inc.
|
-2.08 USD
|
-508.654%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
-830.882%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
-817.391%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-48036.882%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-164315.584%
|
Autolus Therapeutics plc
|
-1.20 USD
|
-955.0%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
-536.181%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
-595.604%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
-210.294%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
-711.538%
|
GRI Bio, Inc.
|
-28.25 USD
|
55.186%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
-367.159%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
-653.571%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
-168.79%
|
INmune Bio, Inc.
|
-1.67 USD
|
-658.084%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
-1482.5%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-65.707%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-0.079%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
73.559%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
-810.791%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-2121.053%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
80.577%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
-400.395%
|
Verastem, Inc.
|
-3.96 USD
|
-219.697%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
-400.395%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
-360.364%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
94.222%
|
Histogen Inc.
|
-3.46 USD
|
-265.896%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
-220.506%
|
Surrozen, Inc.
|
-21.33 USD
|
40.647%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
-691.25%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-375.94%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
-1610.811%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
99.995%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
-526.733%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
-1941.935%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
-706.369%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
-2.76%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
-1030.357%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
-412.551%
|
Apollomics, Inc.
|
-2.32 USD
|
-445.69%
|
Amarin Corporation plc
|
-0.15 USD
|
-8340.0%
|
Mesoblast Limited
|
-0.89 USD
|
-1322.472%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
-165.409%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
-402.381%
|
Synaptogenix, Inc.
|
-29.56 USD
|
57.172%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-7812.5%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-2244.444%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-4265.517%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-2082.759%
|
Exelixis, Inc.
|
0.65 USD
|
2047.692%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
-649.112%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
-377.736%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
-184.494%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-3856.25%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
68.492%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
-671.951%
|
Gritstone bio, Inc.
|
-1.20 USD
|
-955.0%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-104.854%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
-137.523%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
-467.713%
|
Insmed Incorporated
|
-5.34 USD
|
-137.079%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
2.39%
|
MediWound Ltd.
|
-0.75 USD
|
-1588.0%
|
OmniAb, Inc.
|
-0.51 USD
|
-2382.353%
|
Alector, Inc.
|
-1.56 USD
|
-711.538%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
-1322.472%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
-357.04%
|
Zai Lab Limited
|
-3.46 USD
|
-265.896%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
-230.548%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
-555.959%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
-1261.29%
|
Immunic, Inc.
|
-2.11 USD
|
-500.0%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
-174.026%
|
Veracyte, Inc.
|
-1.02 USD
|
-1141.176%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
-1153.465%
|
FibroGen, Inc.
|
-2.92 USD
|
-333.562%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
58.204%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
-132.721%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
30.209%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
282.158%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
52.673%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
1834.247%
|
TG Therapeutics, Inc.
|
0.09 USD
|
14276.932%
|
Galecto, Inc.
|
-36.08 USD
|
64.911%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
-59.446%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-32954.83%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
-268.023%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
79.783%
|
XBiotech Inc.
|
-0.81 USD
|
-1462.963%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-104.854%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
-904.762%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
-441.026%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-2483.673%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
-1166.0%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
-53.455%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
-595.604%
|
Vaxxinity, Inc.
|
-0.45 USD
|
-2713.333%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
-972.881%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
-640.351%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
70.205%
|
NexImmune, Inc.
|
-30.82 USD
|
58.923%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
-236.702%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
-555.959%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
134.17%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
-514.563%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-2201.818%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
-315.082%
|
Ainos, Inc.
|
-3.36 USD
|
-276.786%
|
Pluri Inc.
|
-3.99 USD
|
-217.293%
|
Prothena Corporation plc
|
-2.76 USD
|
-358.696%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-2121.053%
|
Celularity Inc.
|
-11.02 USD
|
-14.882%
|
Rallybio Corporation
|
-1.84 USD
|
-588.043%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
-1040.541%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
-749.664%
|
Omeros Corporation
|
-1.88 USD
|
-573.404%
|
Humacyte, Inc.
|
-1.07 USD
|
-1083.178%
|
Immunocore Holdings plc
|
-1.13 USD
|
-1020.354%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
-580.645%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
-141.143%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
-51.254%
|
CalciMedica, Inc.
|
-7.65 USD
|
-65.49%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
-667.273%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
-381.369%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
-536.181%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
-767.123%
|
Pulmatrix, Inc.
|
-3.87 USD
|
-227.132%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
-81.897%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
-494.366%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
-133.579%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
-74.38%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
-132.294%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
23.964%
|
Nutriband Inc.
|
-0.69 USD
|
-1734.783%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
-254.622%
|
Vor Biopharma Inc.
|
-1.75 USD
|
-623.429%
|
Roivant Sciences Ltd.
|
5.55 USD
|
328.108%
|
Evogene Ltd.
|
-5.23 USD
|
-142.065%
|
ProKidney Corp.
|
-0.57 USD
|
-2121.053%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
-791.549%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
-450.435%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
-220.506%
|
CorMedix Inc.
|
-0.91 USD
|
-1291.209%
|
BioLineRx Ltd.
|
-0.94 USD
|
-1246.809%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
-1072.222%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
-1610.811%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-4964.0%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
-1407.143%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
-341.115%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
-183.221%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
-375.94%
|
MediciNova, Inc.
|
-0.17 USD
|
-7347.059%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
32.263%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-1818.182%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-23.875%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
-140.228%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
-268.023%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
-51.254%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-28222.148%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
-243.089%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
-324.832%
|
Absci Corporation
|
-1.20 USD
|
-955.0%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-218.09%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
-390.698%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
-220.506%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
6430.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
-283.636%
|
Allakos Inc.
|
-2.14 USD
|
-491.589%
|
Imunon, Inc.
|
-2.16 USD
|
-486.111%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
-696.226%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
1341.176%
|
BioAtla, Inc.
|
-2.58 USD
|
-390.698%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-3856.25%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
62.366%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
-505.742%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
-1407.143%
|
XOMA Corporation
|
-4.04 USD
|
-213.366%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
-804.286%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
-478.082%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
-1246.809%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
-259.659%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
-338.062%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
-138.418%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
-873.846%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
-398.425%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
-520.588%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-3164900.0%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
694.366%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-1153.465%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
-256.62%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
-611.236%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
-175.217%
|
Orgenesis Inc.
|
-1.91 USD
|
-562.827%
|
Entera Bio Ltd.
|
-0.31 USD
|
-3983.871%
|
GH Research PLC
|
-0.68 USD
|
-1761.765%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
-390.698%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
49.822%
|
Xencor, Inc.
|
-2.08 USD
|
-508.654%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
-1232.632%
|
Replimune Group, Inc.
|
-3.24 USD
|
-290.741%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
-1425.301%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
29070.252%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-1153.465%
|
Portage Biotech Inc.
|
-3.70 USD
|
-242.162%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-1818.182%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
-491.589%
|
OncoCyte Corporation
|
-3.75 USD
|
-237.6%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
-414.634%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
-49.292%
|
Purple Biotech Ltd.
|
-0.09 USD
|
-13997.996%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
-1941.935%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
-791.549%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
-791.549%
|
HilleVax, Inc.
|
-3.04 USD
|
-316.447%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
-1425.301%
|
Tharimmune, Inc.
|
-107.08 USD
|
88.177%
|
Genprex, Inc.
|
-22.58 USD
|
43.933%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
-749.664%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-5175.0%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-383536.364%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-4421.429%
|
OKYO Pharma Limited
|
-0.00 USD
|
-2109900.0%
|
Savara Inc.
|
-0.33 USD
|
-3736.364%
|
Curis, Inc.
|
-8.96 USD
|
-41.295%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
-205.06%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
-767.123%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
-70.85%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
-744.0%
|
BeiGene, Ltd.
|
-8.45 USD
|
-49.822%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
40.869%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
-227.979%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
-810.791%
|
Erasca, Inc.
|
-0.83 USD
|
-1425.301%
|
bluebird bio, Inc.
|
-1.93 USD
|
-555.959%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-1000.87%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
1522.472%
|
DBV Technologies S.A.
|
-0.76 USD
|
-1565.789%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-1000.87%
|
Moderna, Inc.
|
-12.34 USD
|
-2.593%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
-569.841%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
-1218.75%
|
Molecular Templates, Inc.
|
-1.80 USD
|
-603.333%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
-362.044%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
-744.0%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
-381.369%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
-920.968%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
-333.562%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
-423.14%
|
MacroGenics, Inc.
|
-0.15 USD
|
-8340.0%
|
RenovoRx, Inc.
|
-0.99 USD
|
-1178.788%
|
Adicet Bio, Inc.
|
-3.31 USD
|
-282.477%
|
Prime Medicine, Inc.
|
-2.18 USD
|
-480.734%
|
Aditxt, Inc.
|
-4326.64 USD
|
99.707%
|
Adagene Inc.
|
-0.44 USD
|
-2777.273%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-5928.571%
|
Quantum-Si incorporated
|
-0.68 USD
|
-1761.765%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
-1306.667%
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
-1000.87%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
511.039%
|
SciSparc Ltd.
|
-14.43 USD
|
12.266%
|
Vericel Corporation
|
-0.07 USD
|
-18823.767%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-2288.679%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
-174.62%
|
Generation Bio Co.
|
-1.96 USD
|
-545.918%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
-423.14%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
-573.404%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
-234.921%
|
Invivyd, Inc.
|
-1.81 USD
|
-599.448%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
-353.763%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
-31.328%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
3044.186%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
-262.751%
|
2seventy bio, Inc.
|
-4.42 USD
|
-186.425%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-9638.462%
|
Clene Inc.
|
-9.43 USD
|
-34.252%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
-1425.301%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
-470.27%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-23.875%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
-701.266%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-5654.545%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
1030.882%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
-285.976%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
72.827%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
-238.503%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
-175.817%
|
Evaxion Biotech A/S
|
-8.11 USD
|
-56.104%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
-1061.468%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
-305.769%
|
Trevena, Inc.
|
-54.51 USD
|
76.775%
|
Surrozen, Inc.
|
-21.33 USD
|
40.647%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
-681.481%
|
Cingulate Inc.
|
-311.99 USD
|
95.942%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
57.87%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
-368.889%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
59.28%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
-896.85%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-3321.622%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
-1072.222%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
78.608%
|
Kronos Bio, Inc.
|
-1.95 USD
|
-549.231%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
-591.803%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-3146.154%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
-1291.209%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
-154.728%
|
ImmunityBio, Inc.
|
-1.15 USD
|
-1000.87%
|
Korro Bio, Inc.
|
-53.08 USD
|
76.149%
|
Kineta, Inc.
|
-1.28 USD
|
-889.063%
|
BioVie Inc.
|
-7.30 USD
|
-73.425%
|
Codexis, Inc.
|
-1.12 USD
|
-1030.357%
|
Celularity Inc.
|
-11.02 USD
|
-14.882%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
-243.089%
|
Celcuity Inc.
|
-2.69 USD
|
-370.632%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
-276.786%
|
Cibus, Inc.
|
-25.95 USD
|
51.214%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-791150.0%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
22.663%
|
IN8bio, Inc.
|
-1.00 USD
|
-1166.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
-154.728%
|
Annexon, Inc.
|
-1.77 USD
|
-615.254%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
-8.95%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
5.381%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
88.854%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
-394.531%
|
Eyenovia, Inc.
|
-0.66 USD
|
-1818.182%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
2852.174%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-13904.425%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
-355.396%
|
Arcellx, Inc.
|
-1.47 USD
|
-761.224%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
-1261.29%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
-98.433%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
-701.266%
|
Moolec Science SA
|
-1.50 USD
|
-744.0%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
-1072.222%
|
Geron Corporation
|
-0.32 USD
|
-3856.25%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
-706.369%
|
Royalty Pharma plc
|
3.41 USD
|
471.261%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
-676.687%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
-1734.783%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
-6.835%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
-755.405%
|
Humacyte, Inc.
|
-1.07 USD
|
-1083.178%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
-418.852%
|
89bio, Inc.
|
-2.00 USD
|
-533.0%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
-779.167%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
82.799%
|
Genelux Corporation
|
-1.16 USD
|
-991.379%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-4265.517%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
-1482.5%
|
Notable Labs, Ltd.
|
-5.03 USD
|
-151.69%
|
Liquidia Corporation
|
-1.21 USD
|
-946.281%
|
Mustang Bio, Inc.
|
-6.00 USD
|
-111.0%
|
Immunovant, Inc.
|
-1.88 USD
|
-573.404%
|
Quantum-Si incorporated
|
-0.68 USD
|
-1761.765%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-2777.273%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
-2010.0%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
-462.667%
|
Acasti Pharma Inc.
|
-1.35 USD
|
-837.778%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
-1847.692%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-0.079%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
-363.736%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-3065.0%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
-414.634%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
-562.827%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
-436.441%
|
PepGen Inc.
|
-3.30 USD
|
-283.636%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
15.992%
|
United Therapeutics Corporation
|
21.04 USD
|
160.171%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
-785.315%
|
Solid Biosciences Inc.
|
-4.83 USD
|
-162.112%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-4265.517%
|
Immuneering Corporation
|
-1.88 USD
|
-573.404%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-375.94%
|
Silo Pharma, Inc.
|
-1.20 USD
|
-955.0%
|
Belite Bio, Inc
|
-1.19 USD
|
-963.866%
|
XOMA Corporation
|
-4.04 USD
|
-213.366%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-2121.053%
|
Bionomics Limited
|
-1.02 USD
|
-1141.176%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-372252.941%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-2914.286%
|
uniQure N.V.
|
-6.47 USD
|
-95.672%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
-445.69%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-5928.571%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
-824.088%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
49.197%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-3856.25%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
-711.538%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-13904.425%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
58.204%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
-2045.763%
|
Altimmune, Inc.
|
-1.66 USD
|
-662.651%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-2382.353%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-2914.286%
|
Compugen Ltd.
|
-0.21 USD
|
-5928.571%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
-873.846%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
-136.194%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
74.226%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
-135.316%
|
Zura Bio Limited
|
-2.09 USD
|
-505.742%
|
PolyPid Ltd.
|
-16.99 USD
|
25.486%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
-270.175%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
-135.316%
|
Instil Bio, Inc.
|
-24.00 USD
|
47.25%
|
argenx SE
|
-5.16 USD
|
-145.349%
|
Immunome, Inc.
|
-5.38 USD
|
-135.316%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-3736.364%
|
Verona Pharma plc
|
-0.54 USD
|
-2244.444%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
-180.71%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
-517.561%
|
CervoMed Inc.
|
-0.82 USD
|
-1443.902%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
17.255%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
-198.585%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
-49.822%
|
Moolec Science SA
|
-1.50 USD
|
-744.0%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
-56.489%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
-107.882%
|
AnaptysBio, Inc.
|
-6.08 USD
|
-108.224%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
-963.866%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
-218.09%
|
NeurAxis, Inc.
|
-4.03 USD
|
-214.144%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
-63.777%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
-202.871%
|
Achilles Therapeutics plc
|
-1.74 USD
|
-627.586%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
-180.71%
|
180 Life Sciences Corp.
|
-52.60 USD
|
75.932%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
1961.765%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-3146.154%
|
Nutriband Inc.
|
-0.69 USD
|
-1734.783%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
-545.918%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
19.105%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
-539.394%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
-851.88%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
-1634.247%
|
Palisade Bio, Inc.
|
-27.01 USD
|
53.128%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
-42.728%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
-636.047%
|
Neurogene Inc.
|
-2.83 USD
|
-347.35%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
-216.5%
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
-431.933%
|
Sesen Bio, Inc.
|
-1.99 USD
|
-536.181%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
-529.851%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
47.794%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
-569.841%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
-1218.75%
|
Athira Pharma, Inc.
|
-3.10 USD
|
-308.387%
|
Vaccinex, Inc.
|
-43.68 USD
|
71.016%
|
HCW Biologics Inc.
|
-0.70 USD
|
-1708.571%
|
XOMA Corporation
|
-4.04 USD
|
-213.366%
|
Nektar Therapeutics
|
-1.45 USD
|
-773.103%
|
Arvinas, Inc.
|
-6.62 USD
|
-91.239%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-3164900.0%
|
Merus N.V.
|
-3.00 USD
|
-322.0%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
-603.333%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
-1407.143%
|
Rezolute, Inc.
|
-1.33 USD
|
-851.88%
|
Clene Inc.
|
-9.43 USD
|
-34.252%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
-588.043%
|
BeyondSpring Inc.
|
-0.54 USD
|
-2244.444%
|
Synlogic, Inc.
|
-8.81 USD
|
-43.7%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-122812.621%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
72.989%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
-1105.714%
|
Krystal Biotech, Inc.
|
0.40 USD
|
3265.0%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
-912.8%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
-145.825%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
-1544.156%
|
MannKind Corporation
|
-0.04 USD
|
-28222.148%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
-676.687%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
-40.823%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
-797.872%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
-972.881%
|
CohBar, Inc.
|
-4.13 USD
|
-206.538%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
-1372.093%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-218.09%
|
Legend Biotech Corporation
|
-2.94 USD
|
-330.612%
|
Mural Oncology plc
|
-12.43 USD
|
-1.85%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
-60.864%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
-15.091%
|
Disc Medicine, Inc.
|
-3.43 USD
|
-269.096%
|
Champions Oncology, Inc.
|
-0.54 USD
|
-2244.444%
|
REGENXBIO Inc.
|
-6.02 USD
|
-110.299%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
-169.936%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
-2010.0%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
-307.074%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
-706.369%
|
Vaxart, Inc.
|
-0.57 USD
|
-2121.053%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
-603.333%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
-1878.125%
|
Cellectis S.A.
|
-1.77 USD
|
-615.254%
|
Longeveron Inc.
|
-10.22 USD
|
-23.875%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
-467.713%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
-118.276%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
-824.088%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
-227.979%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-17124.49%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
-1523.077%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
-483.41%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
-362.044%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-3856.25%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
190.107%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
-1094.34%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-2288.679%
|
Veru Inc.
|
-1.10 USD
|
-1050.909%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-2160.714%
|
Cingulate Inc.
|
-311.99 USD
|
95.942%
|
Passage Bio, Inc.
|
-1.86 USD
|
-580.645%
|
Context Therapeutics Inc.
|
-1.50 USD
|
-744.0%
|
Exicure, Inc.
|
-2.11 USD
|
-500.0%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
-434.177%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
-1205.155%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
23.827%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
-295.625%
|
Nuvalent, Inc.
|
-2.17 USD
|
-483.41%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
-420.988%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
-388.803%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
-889.063%
|
OmniAb, Inc.
|
-0.51 USD
|
-2382.353%
|
Anew Medical, Inc.
|
0.14 USD
|
9142.857%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
-2010.0%
|
Lipocine Inc.
|
-3.14 USD
|
-303.185%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
-408.434%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-2382.353%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-65.707%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
-1261.29%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
-508.654%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
-39.89%
|
Ocugen, Inc.
|
-0.26 USD
|
-4769.231%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
-418.852%
|
Q32 Bio Inc.
|
-35.16 USD
|
63.993%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-3065.0%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
-323.411%
|
Equillium, Inc.
|
-0.38 USD
|
-3231.579%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-12659900.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
-1502.532%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
94.963%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
-851.88%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
51.826%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
-619.318%
|
Dominari Holdings Inc.
|
-4.38 USD
|
-189.041%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
-332.082%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
-30.381%
|
Bio-Techne Corporation
|
1.07 USD
|
1283.178%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
-100.0%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
683.41%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
-526.733%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
-866.412%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
-301.905%
|
Nkarta, Inc.
|
-2.40 USD
|
-427.5%
|
BioCardia, Inc.
|
-8.19 USD
|
-54.579%
|
Iterum Therapeutics plc
|
-2.96 USD
|
-327.703%
|